Alga Ecklonia bicyclis, Tribulus terrestris, and Glucosamine Oligosaccharide Improve Erectile Function, Sexual Quality of Life, and Ejaculation Function in Patients with Moderate Mild-Moderate Erectile Dysfunction : A Prospective, Randomized, Placebo-Controlled, Single-Blinded Study

Abstract EN

We aimed to evaluate the efficacy of oral therapy with alga Ecklonia bicyclis, Tribulus terrestris, and glucosamine oligosaccharide (Tradamix TX1000) in patients with erectile dysfunction (ED) at 3 months of follow-up.

From January 2013 to September 2013, 177 patients diagnosed with mild-moderate ED (IIEF-EF < 26) were enrolled in this multicenter, single-blinded, placebo-controlled study and randomized in Group A (Tradamix, n=87) and Group B (placebo, n=90).

Penile color Doppler ultrasound measures, IIEF-15 questionnaire, male sexual health questionnaire-ejaculation disorder (MSHQ-EjD), and sexual quality of life (SQoL-M) were collected.

We observed significant changes of the IIEF-15 in Group A (mean difference: 11.54; P<0.05) at 3 months versus Group B (P<0.05).

PSV (P<0.05), IIEF-intercourse satisfaction (P<0.05), IIEF-orgasmic function (mean P<0.05), IIEF-sexual desire (P<0.05), IIEF-overall satisfaction (P<0.05), MSHQ-EjD (mean difference: 1.21; P<0.05), and SQoL-M (mean difference: 10.2; P<0.05) were significantly changed in Group A versus baseline and Group B.

Patients with moderate arterial dysfunction showed significant increase of PSV (P<0.05), IIEF-EF (P<0.05), MSHQ-EjD (P<0.05), and SQoL-M (P<0.05) in Group A.

Therapy with Tradamix improves erectile and ejaculation function and sexual quality of life in patients with mild-moderate ED and in particular for those with moderate arterial dysfunction.